Agustin Suarez, MD
Hematology & Oncology · Carriere, MSNPI 1528023900
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 26 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 16 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $416 and has fallen 56.7% since, to $180 in 2025. That places this record below the midpoint for hematology & oncology clinicians in MS, where the typical reported total is $9,632.
Across 26 payments — averaging $65.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Exelixis Inc.$352
- AstraZeneca$238
- Astellas Pharma US Inc$172
- Takeda Pharmaceuticals U.S.A., Inc.$136
- Daiichi Sankyo Inc.$125
- Coherus Oncology, Inc.$125
- plus $560 from 10 others
What the payments were for
- Food & beverage$1,709100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Exelixis Inc. | 3 | $352 |
| AstraZeneca | 3 | $238 |
| Astellas Pharma US Inc | 3 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $136 |
| Daiichi Sankyo Inc. | 1 | $125 |
| Coherus Oncology, Inc. | 1 | $125 |
| Merck | 1 | $125 |
| Gilead | 1 | $100 |
| Blueprint Medicines Corporation | 1 | $70 |
| Springworks Therapeutics, Inc. | 1 | $67 |
| Novartis | 4 | $62 |
| E.r. Squibb & Sons, L.L.C. | 1 | $60 |
| Johnson & Johnson | 1 | $25 |
| GSK | 1 | $19 |
| AbbVie | 1 | $18 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,709 in reported general payments places this provider in the 10th percentile of 57 hematology & oncology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 95 | $1,320 |
| Morphine Sulfate ErMorphine Sulfate | 49 | $914 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $780 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $389 |
| Methadone Hcl | 24 | $231 |
| Duloxetine Hcl | 32 | $205 |
| Lorazepam | 18 | $196 |
| Olanzapine | 20 | $192 |
| Dexamethasone | 12 | $178 |
| Gabapentin | 32 | $177 |
| Tamsulosin Hcl | 22 | $172 |
| Clonazepam | 41 | $136 |
| Omeprazole | 13 | $133 |
| Alprazolam | 19 | $105 |
| Mirtazapine | 11 | $71 |
Paid to pharmacies, not to this prescriber.
Other hematology & oncology in Carriere
- Solly ChedidPascagoula$1.7M
- Carter MilnerJackson$248K
- Guangzhi QuJackson$59K
- Jennifer EubanksMeridian$44K
- Daniel PattersonPascagoula$36K
- John HeneganJackson$35K
- Pamela TuliGulfport$27K
- Sonia BennSouthaven$26K
- Ronald DelrieMcComb$24K
- Matthew CassellMeridian$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.